{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:26:01Z","timestamp":1793330761527,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/ftd.0b013e31822724f0","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T13:02:04Z","timestamp":1310130124000},"page":"443-452","source":"Crossref","is-referenced-by-count":45,"title":["Methadone, Cocaine, Opiates, and Metabolite Disposition in Umbilical Cord and Correlations to Maternal Methadone Dose and Neonatal Outcomes"],"prefix":"10.1097","volume":"33","author":[{"given":"Ana","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendre\u00e9 E","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolley E","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa R","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaa M","family":"Shakleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0379-0738(02)00160-3","article-title":"Drug abuses smallest victims: in utero drug exposure.","volume":"128","author":"Huestis","year":"2002","journal-title":"Forensic Sci Int"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3109\/10826089309062191","article-title":"The consequences of prenatal substance use for the developing fetus, newborn, and young child.","volume":"28","author":"Behnke","year":"1993","journal-title":"Int J Addict"},{"key":"R4-12-20210129","first-page":"567","article-title":"Smoking and illicit drug use during pregnancy: impact on neonatal outcome.","volume":"51","author":"Miles","year":"2006","journal-title":"J Reprod Med"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0892-0362(96)00062-1","article-title":"The effects of prenatal cocaine use on neonatal neurobehavioral status.","volume":"18","author":"Richardson","year":"1996","journal-title":"Neurotoxicol Teratol"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1651-2227.1994.tb13383.x","article-title":"Development after prenatal exposure to cocaine, heroin and methadone.","volume":"404","author":"van Baar","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/PDR.0b013e3181bc035d","article-title":"Prenatal methadone exposure and neonatal neurobehavioral functioning.","volume":"66","author":"Velez","year":"2009","journal-title":"Pediatr Res"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes.","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/02791072.1991.10472236","article-title":"Treatment issues for opioid-dependent women during the perinatal period.","volume":"23","author":"Finnegan","year":"1991","journal-title":"J Psychoactive Drugs"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1360-0443.2008.02283.x","article-title":"Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates.","volume":"103","author":"Winklbaur","year":"2008","journal-title":"Addiction"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.","volume":"15","author":"Bakstad","year":"2009","journal-title":"Eur Addict Res"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugalcdep.2006.08.024","article-title":"Management of neonatal abstinence syndrome in neonates born to opioid maintained women.","volume":"87","author":"Ebner","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","article-title":"Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.","volume":"116","author":"Dryden","year":"2009","journal-title":"BJOG"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphism.","volume":"12","author":"Li","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.","volume":"16","author":"Gerber","year":"2004","journal-title":"Chirality"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0300-483X(02)00492-4","article-title":"Polymorphism of cytochrome P450 and xenobiotic toxicity.","volume":"181-","author":"Ingelman-Sundberg","year":"2002","journal-title":"Toxicology"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.ftd.0000211812.27558.6e","article-title":"Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine.","volume":"28","author":"Maurer","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/clpt.1993.182","article-title":"Ethnic differences in response to morphine.","volume":"54","author":"Zhou","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0009-9236(01)45600-1","article-title":"Ethnicity influences morphine pharmacokinetics and pharmacodynamics.","volume":"70","author":"Cepeda","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/bja\/aef284","article-title":"Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability.","volume":"89","author":"Williams","year":"2002","journal-title":"Br J Anaesth"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00414-009-0340-0","article-title":"Fatal and severe codeine intoxication in 3-year-old twinsinterpretation of drug and metabolite concentrations.","volume":"123","author":"Ferreiros","year":"2009","journal-title":"Int J Legal Med"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1056\/NEJMoa041888","article-title":"Codeine intoxication associated with ultrarapid CYP2D6 metabolism.","volume":"351","author":"Gasche","year":"2004","journal-title":"N Engl J Med"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.","volume":"75","author":"Marzolini","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.2008.156","article-title":"Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.","volume":"84","author":"Kacinko","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1373\/clinchem.2010.147876","article-title":"Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.","volume":"56","author":"Gray","year":"2010","journal-title":"Clin Chem"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.jp.7211416","article-title":"Testing for fetal exposure to illicit drugs using umbilical cord tissue vs. meconium.","volume":"26","author":"Montgomery","year":"2006","journal-title":"J Perinatol"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.jchromb.2009.07.028","article-title":"Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord.","volume":"877","author":"de Castro","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jat\/33.5.243","article-title":"Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry.","volume":"33","author":"de Castro","year":"2009","journal-title":"J Anal Toxicol"},{"key":"R33-12-20210129","first-page":"369","article-title":"Determination of methadone, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine, 2-ethyl-5-methyl-3, 3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B, Analyt Technol Biomed Life Sci.","volume":"814","author":"Choo","year":"2005","journal-title":""},{"key":"R34-12-20210129","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00216-009-2680-5","article-title":"A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium.","volume":"393","author":"Gray","year":"2009","journal-title":"Anal Bioanal Chem"},{"key":"R35-12-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.","volume":"75","author":"Choo","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"R36-12-20210129","first-page":"936","article-title":"Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal.","volume":"81","author":"Doberczak","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R37-12-20210129","doi-asserted-by":"crossref","first-page":"F390","DOI":"10.1136\/adc.2003.036863","article-title":"Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?","volume":"89","author":"Kuschel","year":"2004","journal-title":"Arch Dis Child Fetal and Neonatal Ed"},{"key":"R38-12-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1440-1754.1991.tb00360.x","article-title":"Methadone levels and neonatal withdrawal.","volume":"27","author":"Mack","year":"1991","journal-title":"J Paediatr Child Health"},{"key":"R39-12-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00121-6","article-title":"Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.","volume":"61","author":"Eap","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"R40-12-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0002-9378(77)90588-9","article-title":"Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome.","volume":"129","author":"Harper","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"R41-12-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-3782(77)90017-2","article-title":"The narcotic-dependent mother: fetal and neonatal consequences.","volume":"1","author":"Kandall","year":"1977","journal-title":"Early Hum Dev"},{"key":"R42-12-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1749-6632.1978.tb16770.x","article-title":"Management of pregnant drug-dependent women.","volume":"311","author":"Finnegan","year":"1978","journal-title":"Ann N Y Acad Sci"},{"key":"R43-12-20210129","first-page":"331","article-title":"Perinatal substance abuse: comments and perspectives.","volume":"15","author":"Finnegan","year":"1991","journal-title":"Semin Perinatol"},{"key":"R44-12-20210129","first-page":"169","article-title":"Disposition of methadone and its relationship to severity of withdrawal in the newborn.","volume":"2","author":"Rosen","year":"1975","journal-title":"Addict Dis"},{"key":"R45-12-20210129","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-3476(76)81074-8","article-title":"Pharmacologic observations on the neonatal withdrawal syndrome.","volume":"88","author":"Rosen","year":"1976","journal-title":"J Pediatr"},{"key":"R46-12-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bcp.2004.09.008","article-title":"Bidirectional transfer of methadone across human placenta.","volume":"69","author":"Nekhayeva","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"R47-12-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0002-9378(75)90461-5","article-title":"Methadone assays in pregnant women and progeny.","volume":"121","author":"Blinick","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"R48-12-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jchromb.2008.04.006","article-title":"Validated method for the simultaneous determination of methadone and its main metabolites (EDDP and EMDP) in plasma of umbilical cord blood by gas chromatography-mass spectrometry.","volume":"867","author":"Nikolaou","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R49-12-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/jat\/17.1.62","article-title":"Determination of cocaine and its major metabolite, benzoylecgonine, in amniotic fluid, umbilical cord blood, umbilical cord tissue, and neonatal urine: a case study.","volume":"17","author":"Moore","year":"1993","journal-title":"J Anal Toxicol"},{"key":"R50-12-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jat\/21.2.97","article-title":"Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue.","volume":"21","author":"Winecker","year":"1997","journal-title":"J Anal Toxicol"},{"key":"R51-12-20210129","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/jp.2008.97","article-title":"Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.","volume":"28","author":"Montgomery","year":"2008","journal-title":"J Perinatol"},{"key":"R52-12-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/FTD.0b013e3182055f14","article-title":"Nicotine and metabolites in paired umbilical cord tissue and meconium specimens.","volume":"33","author":"Marin","year":"2010","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e31822724f0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:35:33Z","timestamp":1786044933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201108000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31822724f0","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}